NCT07897565

Safety and Efficacy of Gemcitabine, Toripalimab and Dose- Modified Lenvatinib in Elderly Patients With Advanced Biliary Tract Cancer Intolerant to Conventional Chemotherapy

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-10-12Est. Completion: 2027-12-31

Enrollment target: 39 participants

Biliary CancerBile Duct CancerCancer of the Bile Duct

Background: Biliary tract carcinoma (BTC) is cancer of the slender tubes that carry fluids in the liver. People with ad…

Bethesda, United StatesEst. completion Jun 1, 2040

Advanced Biliary Tract Cancer

This is a study to evaluate the clinical activity of the combination of fluorouracil, leucovorin, and nanoliposomal irin…

Washington D.C., United StatesEst. completion Sep 3, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.